Skip to main content
SpringerLink
Log in

Cost-Effectiveness Analysis of Intrabeam System Introduction to the Czech Healthcare System Environment

  • Conference paper
  • First Online:
World Congress on Medical Physics and Biomedical Engineering 2018

Part of the book series: IFMBE Proceedings ((IFMBE,volume 68/2))

  • 3032 Accesses

Abstract

Backround: Intrabeam system is a technology used in oncology for intraoperative radiotherapy (IORT), a technique of partial delivery of radiation therapy to the tumour bed during surgery. The aim of this study is to evaluate cost effectiveness of the Intrabeam system compared to the standard treatment with external beam radiotherapy (EBRT) in early stage breast cancer treatment in order to reach a decision on a possible introduction of the technology to the Czech healthcare system. Methods: In order to determine the clinical effects, a worldwide literature review was conducted. The cost of the Intrabeam system was estimated based on available information about acquisitions of the system worldwide in the last 5 years. The cost of treatment was calculated from the perspective of a healthcare payer, and all the information gathered was summarized in a Markov model to finalize the cost-effectiveness calculation. A sensitivity analysis was performed. Results: The input of the model was based on the TARGIT-A pragmatic randomized controlled trial—the largest and most comprehensive study among 26 selected studies from the literature review. The estimated purchase cost of the system for the Czech Republic was determined in the range of CZK 16–20 million without VAT. Based on the findings, three versions (baseline, optimistic, pessimistic) of the calculation for IORT interventions using Intrabeam were determined. In the baseline scenario, the cost of the Intrabeam system intervention was CZK 38 559, the ICER value was CZK 53 483 saved per 1 QALY lost. The results of the sensitivity analysis are consistent with the results of the baseline scenario. The ICER value is not above the cost-effectiveness threshold (currently a little above CZK 1.2 million), which is required to consider the technology cost effective. Conclusion: According to the results of the cost-effectiveness analysis, we do not currently recommend the Intrabeam system to be introduced into the Czech healthcare system.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution

Subscribe and save

Springer+ Basic
$34.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 299.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 379.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Similar content being viewed by others

References

  1. Vaidya JS, Joseph DJ, Tobias JS, Bulsara M, Wenz F, Saunders C, et al. Targeted intraoperative radiotherapy versus whole breast radiotherapy for breast cancer (TARGIT-A trial): an international, prospective, randomised, non-inferiority phase 3 trial. Lancet (London, England). 2010 Jul 10; 376(9735):91–102.

    Google Scholar 

  2. Park CC, Yom SS, Podgorsak MB, Harris E, Price RA Jr, Bevan A, et al. American Society for Therapeutic Radiology and Oncology (ASTRO) Emerging Technology Committee report on electronic brachytherapy. Int J Radiat Oncol Biol Phys. 2010 Mar 15; 76(4):963–72.

    Google Scholar 

  3. Carl Zeiss Meditec Inc. INTRABEAM Radiotherapy System Uniquely Flexible Radiotherapy [Internet]. [cited 2015 Sep 30]. Available from: http://www.zeiss.com/meditec/en_de/products—solutions/intraoperative-radiotherapy/intrabeam-for-breast-cancer/intrabeam.html.

  4. Dušek L, Mužík J, Kubásek M, Koptíková J, Žaloudík J, Vyzula R, et al. Epidemiology of malignant tumors in the Czech Republic (Epidemiologie zhoubných nádorů v České republice) [Internet web page; cited 2016 Dec 30]. Version 7.0. Available from: http://www.svod.cz.

  5. Deneve JL, Hoefer RA, Harris EER, Laronga C. Accelerated partial breast irradiation: a review and description of an early North American surgical experience with the intrabeam delivery system. Cancer Control. 2012 Oct; 19(4):295–308.

    Google Scholar 

  6. The Czech Republic. Act No. 324/2014 Coll. defining point value and health care expenses paid by public health care insurance and regulatory limits (Vyhláška č. 324/2014 Sb. hodnoty bodu, úhrady zdravotní péče hrazené z pojištění pro r. 2015). 2014. Available from: https://portal.gov.cz/app/zakony/zakon.jsp?page=0&nr=324~2F2014&rpp=15#seznam.

  7. Picot J, Copley V, Colquitt JL, Kalita N, Hartwell D, Bryant J. The INTRABEAM® Photon Radiotherapy System for the adjuvant treatment of early breast cancer: a systematic review and economic evaluation. Health Technol Assess (Rockv). 2015; 19(69):1–190.

    Google Scholar 

  8. Czech Statistical Office (Český statistický úřad). Life tables (Úmrtnostní tabulky) [Internet; cited 2015 Oct 26]. Available from: https://www.czso.cz/csu/czso/umrtnostni_tabulky.

  9. WHO. The world health report 2002 - Reducing Risks, Promoting Healthy Life. 2002; Available from: http://www.who.int/whr/2002/en/.

  10. Vaidya JS, Wenz F, Bulsara M, Tobias JS, Joseph DJ, Keshtgar M, et al. Risk-adapted targeted intraoperative radiotherapy versus whole-breast radiotherapy for breast cancer: 5-year results for local control and overall survival from the TARGIT-A randomised trial. Lancet (London, England). 2014 Feb 15; 383(9917):603–13.

    Google Scholar 

  11. Engel D, Schnitzer A, Brade J, Blank E, Wenz F, Suetterlin M, et al. Are Mammographic Changes in the Tumor Bed More Pronounced After Intraoperative Radiotherapy for Breast Cancer? Subgroup Analysis from a Randomized Trial. Breast J. 2013 Jan; 19(1):92–5.

    Google Scholar 

  12. Elsberger B, Romsauerova A, Vinnicombe S, Whelehan P, Brown DC, Dewar JA, et al. Comparison of mammographic findings after intraoperative radiotherapy or external beam whole breast radiotherapy. Eur J Surg Oncol. 2014 Feb; 40(2):163–7.

    Google Scholar 

  13. Keshtgar MRS, Vaidya JS, Tobias JS, Wenz F, Joseph D, Stacey C, et al. Targeted Intraoperative Radiotherapy for Breast Cancer in Patients in Whom External Beam Radiation Is Not Possible. Int J Radiat Oncol. 2011 May; 80(1):31–8.

    Google Scholar 

  14. Keshtgar MMRS, Williams NRN, Bulsara M, Saunders C, Flyger H, Cardoso JS, et al. Objective assessment of cosmetic outcome after targeted intraoperative radiotherapy in breast cancer: results from a randomised controlled trial. Breast cancer Res. 2013 Aug; 140(3):519–25.

    Google Scholar 

  15. Sperk E, Welzel G, Keller A, Kraus-Tiefenbacher U, Gerhardt A, Sütterlin M, et al. Late radiation toxicity after intraoperative radiotherapy (IORT) for breast cancer: results from the randomized phase III trial TARGIT A. Breast Cancer Res Treat. 2012 Aug; 135(1):253–60.

    Google Scholar 

  16. Tuschy B, Berlit S, Romero S, Sperk E, Wenz F, Kehl S, et al. Clinical aspects of intraoperative radiotherapy in early breast cancer: short-term complications after IORT in women treated with low energy x-rays. Radiat Oncol. 2013 Jan; 8:95.

    Google Scholar 

  17. Welzel G, Hofmann F, Blank E, Kraus-Tiefenbacher U, Hermann B, Sütterlin M, et al. Health-related quality of life after breast-conserving surgery and intraoperative radiotherapy for breast cancer using low-kilovoltage X-rays. Ann Surg Oncol. 2010 Oct; 17 Suppl 3:359–67.

    Google Scholar 

  18. Welzel G, Boch A, Sperk E, Hofmann F, Kraus-Tiefenbacher U, Gerhardt A, et al. Radiation-related quality of life parameters after targeted intraoperative radiotherapy versus whole breast radiotherapy in patients with breast cancer: results from the randomized phase III trial TARGIT-A. Radiat Oncol. 2013 Jan; 8:9.

    Google Scholar 

  19. Xie X, Dendukuri N, McGregor M. Single-dose Intraoperative Radiotherapy Using Intrabeam® for Early-stage Breast cancer: A Health Technology Assessment [Internet]. Montreal (Canada); 2012. [cited 2015 Oct 26]. Available from: https://www.mcgill.ca/tau/sites/mcgill.ca.tau/files/muhc_tau_2012_63_intrabeam.pdf.

  20. Swedish Agency for Health Technology Assessment and Assessment of Social Services. Intraoperativ strålbehandling med Intrabeam vid primär operation för bröstcancer [Internet]. 2013. Available from: http://plus.lj.se/info_files/infosida40495/Intraoperativ_stralbehandling_brostkirurgi.pdf.

  21. National Health Committee. Intraoperative Radiotherapy (IORT): An Overview [Internet]. Wellington: National Health Committee; 2015. Available from: http://www.moh.govt.nz/notebook/nbbooks.nsf/0/47935E07292B2EEFCC257F7F0007A1F0/$file/iort-t2-update-post-consultation.pdf.

  22. TED Tenders electronic daily. AT-Feldkirch: The equipment and accessories for radiotherapy 2010/S 77-114201 Contract award notice [Internet]. [cited 2015 Oct 21]. Available from: http://ted.europa.eu/udl?uri=TED:NOTICE:114201-2010:TEXT:CS:HTML.

  23. TED Tenders electronic daily. Poland-Wałbrzych: medical equipments 2014/S 249-441526 Contract award notice [Internet]. [cited 2015 Oct 21]. Available from: http://ted.europa.eu/udl?uri=TED:NOTICE:441526-2014:TEXT:CS:HTML.

  24. TED Tenders electronic daily. Poland-Wałbrzych: medical equipments 2015/S 179-325006 Contract award notice [Internet]. [cited 2015 Oct 21]. Available from: http://ted.europa.eu/udl?uri=TED:NOTICE:325006-2015:TEXT:CS:HTML.

  25. TED Tenders electronic daily. France-Caen: X-ray therapy devices 2015/S 191-345605 Contract award notice [Internet]. [cited 2015 Oct 21]. Available from: http://ted.europa.eu/udl?uri=TED:NOTICE:345605-2015:TEXT:CS:HTML.

  26. Bartelink H. Intraoperative radiotherapy for breast cancer: tail wagging the dog? Lancet Oncol. 2004 Apr; 5(4):207–8.

    Google Scholar 

  27. Veronesi U, Orecchia R, Maisonneuve P, Viale G, Rotmensz N, Sangalli C, et al. Intraoperative radiotherapy versus external radiotherapy for early breast cancer (ELIOT): a randomised controlled equivalence trial. Lancet Oncol. 2013 Dec;14(13):1269–77.

    Google Scholar 

  28. Kreike B, Hart AAM, van de Velde T, Borger J, Peterse H, Rutgers E, et al. Continuing Risk of Ipsilateral Breast Relapse After Breast-Conserving Therapy at Long-Term Follow-up. Int J Radiat Oncol. 2008; 71(4):1014–21.

    Google Scholar 

  29. Shah C, Lanni TB, Saini H, Nanavati A, Wilkinson J Ben, Badiyan S, et al. Cost-efficacy of acceleration partial-breast irradiation compared with whole-breast irradiation. Breast Cancer Res Treat. 2013 Feb; 138(1):127–35.

    Google Scholar 

  30. Alvarado MD, Mohan AJ, Esserman LJ, Park CC, Harrison BL, Howe RJ, et al. Cost-effectiveness analysis of intraoperative radiation therapy for early-stage breast cancer. Ann Surg Oncol. 2013 Sep; 20(9):2873–80.

    Google Scholar 

  31. Grobmyer SR, Lightsey JL, Bryant CM, Shaw C, Yeung A, Bhandare N, et al. Low-kilovoltage, single-dose intraoperative radiation therapy for breast cancer: results and impact on a multidisciplinary breast cancer program. J Am Coll Surg. 2013 Apr; 216(4):617-23-4.

    Google Scholar 

  32. Williams NR, Pigott KH, Brew-Graves C, Keshtgar MRS. Intraoperative radiotherapy for breast cancer. Gland Surg. 2014 May; 3(2):109–19.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Faculty of Biomedical Engineering, Czech Technical University in Prague, Kladno, Czech Republic

    Vojtěch Kamenský, Gleb Donin, Veronika Burianová, Ondřej Gajdoš, Vladimír Rogalewicz, Ivana Kubátová, Silvie Jeřábková & Peter Kneppo

Authors
  1. Vojtěch Kamenský
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Gleb Donin
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Veronika Burianová
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Ondřej Gajdoš
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Vladimír Rogalewicz
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Ivana Kubátová
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Silvie Jeřábková
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Peter Kneppo
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Vojtěch Kamenský .

Editor information

Editors and Affiliations

  1. CIIRC, Czech Technical University in Prague, Prague, Czech Republic

    Lenka Lhotska

  2. Institute of Clinical and Experimental Medicine, Prague, Czech Republic

    Lucie Sukupova

  3. Faculty of Electrical Engineering and Computing, University of Zagreb, Zagreb, Croatia

    Igor Lacković

  4. Department of Radiation Physics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA

    Geoffrey S. Ibbott

Rights and permissions

Reprints and permissions

Copyright information

© 2019 Springer Nature Singapore Pte Ltd.

About this paper

Check for updates. Verify currency and authenticity via CrossMark

Cite this paper

Kamenský, V. et al. (2019). Cost-Effectiveness Analysis of Intrabeam System Introduction to the Czech Healthcare System Environment. In: Lhotska, L., Sukupova, L., Lacković, I., Ibbott, G. (eds) World Congress on Medical Physics and Biomedical Engineering 2018. IFMBE Proceedings, vol 68/2. Springer, Singapore. https://doi.org/10.1007/978-981-10-9038-7_19

Download citation

  • DOI: https://doi.org/10.1007/978-981-10-9038-7_19

  • Published:

  • Publisher Name: Springer, Singapore

  • Print ISBN: 978-981-10-9037-0

  • Online ISBN: 978-981-10-9038-7

  • eBook Packages: EngineeringEngineering (R0)

Publish with us

Policies and ethics

Search

Navigation